Gushengtang Seeks Fresh 10% Share Buyback Mandate at Extraordinary Meeting

Gushengtang Holdings Limited ( (HK:2273) ) has issued an update.

Gushengtang Holdings Limited has called an extraordinary general meeting for May 12, 2026, in Guangzhou to seek shareholder approval for a new share repurchase mandate. The proposal would authorize the board to buy back up to 10% of the company’s issued shares, excluding treasury shares, on the Hong Kong Stock Exchange or other recognized exchanges during a defined mandate period.

If approved, the new authorization will replace the existing buyback mandate granted at the June 20, 2025 annual general meeting and revoke any similar prior approvals still in effect. The move would give directors renewed flexibility to manage the company’s capital structure and potentially support the share price, with the mandate lasting until the next annual general meeting or its earlier revocation by shareholders.

The most recent analyst rating on (HK:2273) stock is a Sell with a HK$24.50 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.

More about Gushengtang Holdings Limited

Gushengtang Holdings Limited is a company incorporated in the Cayman Islands with limited liability and listed on the Stock Exchange of Hong Kong under stock code 2273. The firm operates within the healthcare sector, focusing on traditional Chinese medicine services and related healthcare offerings in mainland China, particularly in Guangzhou and other urban markets.

Average Trading Volume: 1,533,039

Technical Sentiment Signal: Hold

Current Market Cap: HK$6.77B

Find detailed analytics on 2273 stock on TipRanks’ Stock Analysis page.